Insight Briefs30 October 2025 Implications of Assessing Overall Survival in Oncology Studies The FDA’s August 2025 draft guidance reshapes oncology clinical trials by requiring pre-specified overall survival (OS) analysis in... Learn more
Insight Briefs27 October 2025 The Patient Experience Paradox: eCOA Strategy Overhaul Discover how the EMA’s new Patient Experience Data (PED) guidance and the EU HTA Regulation are reshaping evidence... Learn more
Insight Briefs30 September 2025 Automated Evidence Generation for Regulatory-Grade Real-World Data Manual data abstraction can’t keep up with new FDA and EMA RWE standards. This whitepaper explains how automated... Learn more
Insight Briefs25 September 2025 The EMR Interoperability Dream vs. Clinical Research RealityA Practical Guide to the 21st Century Cures Act, FHIR Data, and Bridging the Gap for Regulatory-Grade Evidence Discover the real-world challenges of EMR interoperability in clinical research. Learn how the 21st Century Cures Act, FHIR... Learn more
Insight Briefs18 September 2025 ICH GCP E6(R3) Implementation: Practical Approaches and Real-World Considerations ICH GCP E6(R3) implementation requires strategic planning beyond basic compliance. This practical guide covers realistic 12-18 month timelines,... Learn more
Insight Briefs16 September 2025 Decentralized Clinical Trial Platforms in 2025: A Practical Guide for Clinical Operations DCT platform evaluation guide: integration strategies, vendor comparison, implementation timelines for clinical operations teams. Learn more
Insight Briefs14 August 2025 Navigating the eCOA Vendor Landscape in 2025: What Clinical Teams Really Need to Know The eCOA market reached $2.27 billion in 2025 with 16.1% projected growth, yet vendor selection remains critical for... Learn more
Insight Briefs7 August 2025 Optimizing eCOA in Oncology Trials: Patient-Focused Data Capture for Cancer Research Oncology leads clinical innovation with 7,747 trials registered through 2022, yet only 7% of cancer patients participate. This... Learn more